RAFAEL HOLDINGS, INC. Income (Loss) from Equity Method Investments
RAFAEL HOLDINGS, INC. (RFL) reported Income (Loss) from Equity Method Investments of -$1.63 million for the 12-month period ending 2024-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2024-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2024-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2024-01-31 was -$1.63M.
- RAFAEL HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2022-07-31 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. income (loss) from equity method investments for fiscal 2024 was -$1.63M.
- RAFAEL HOLDINGS, INC. income (loss) from equity method investments for fiscal 2022 was -$575.00K, a 250.13% decline from fiscal 2021.
- RAFAEL HOLDINGS, INC. income (loss) from equity method investments for fiscal 2021 was $383.00K, a 99.48% increase from fiscal 2020.
- RAFAEL HOLDINGS, INC. income (loss) from equity method investments for fiscal 2020 was $192.00K.
| Period end | Income (Loss) from Equity Method Investments 0 month | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 6 month as first filed | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|---|---|
| 2024-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | -$1.63M derived: sum of 3 quarters · filed 2025-10-29 | -$1.63M 10-K · filed 2025-10-29 | ||
| 2024-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | -$1.63M derived: sum of 2 quarters · filed 2025-06-11 | -$1.63M 10-Q · filed 2025-06-11 | |||
| 2024-01-31 | -$1.63M 10-Q · filed 2025-03-14 | -$1.63M 10-Q · filed 2025-03-14 | ||||
| 2022-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $0.00 derived: sum of 2 quarters · filed 2023-06-13 | $0.00 derived: sum of 3 quarters · filed 2023-06-13 | -$575.00K 10-K · filed 2022-10-31 | ||
| 2022-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $0.00 derived: sum of 2 quarters · filed 2023-06-13 | -$575.00K 10-Q · filed 2023-06-13 | -$480.00K derived: sum of 4 quarters · filed 2023-06-13 | ||
| 2022-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$575.00K 10-Q · filed 2023-03-14 | -$480.00K derived: sum of 3 quarters · filed 2023-03-14 | -$384.00K derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2021-10-31 | -$575.00K 10-Q · filed 2022-12-13 | -$480.00K derived: sum of 2 quarters · filed 2022-12-13 | -$384.00K derived: sum of 3 quarters · filed 2022-12-13 | -$288.00K derived: sum of 4 quarters · filed 2022-12-13 | ||
| 2021-07-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $191.00K derived: sum of 2 quarters · filed 2022-10-31 | $287.00K derived: sum of 3 quarters · filed 2022-10-31 | $383.00K 10-K · filed 2022-10-31 | ||
| 2021-04-30 | $96.00K 10-Q · filed 2022-06-14 | $192.00K derived: sum of 2 quarters · filed 2022-06-14 | $288.00K 10-Q · filed 2022-06-14 | $427.00K derived: sum of 4 quarters · filed 2022-06-14 | ||
| 2021-01-31 | $96.00K 10-Q · filed 2022-03-17 | $192.00K 10-Q · filed 2022-03-17 | $331.00K derived: sum of 3 quarters · filed 2022-03-17 | $384.00K derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2020-10-31 | $96.00K 10-Q/A · filed 2022-02-28 | $235.00K derived: sum of 2 quarters · filed 2022-02-28 | $288.00K derived: sum of 3 quarters · filed 2022-02-28 | |||
| 2020-07-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $192.00K derived: sum of 2 quarters · filed 2021-10-18 | $192.00K 10-K · filed 2021-10-18 | |||
| 2020-04-30 | $53.00K 10-Q · filed 2021-06-14 | $53.00K 10-Q · filed 2021-06-14 | ||||
| 2019-01-31 | $103.00K 10-Q · filed 2020-03-05 | $330.00K 10-Q · filed 2020-03-05 | $93.00K derived: sum of 3 quarters · filed 2020-03-05 | $96.00K derived: sum of 4 quarters · filed 2020-03-05 | ||
| 2018-10-31 | -$10.00K 10-Q · filed 2019-12-09 | -$10.00K derived: sum of 2 quarters · filed 2019-12-09 | -$7.00K derived: sum of 3 quarters · filed 2019-12-09 | -$10.00K derived: sum of 4 quarters · filed 2019-12-09 | ||
| 2018-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $3.00K derived: sum of 2 quarters · filed 2019-10-04 | $0.00 derived: sum of 3 quarters · filed 2019-10-04 | -$104.00K 10-K · filed 2019-10-04 | ||
| 2018-04-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | $0.00 derived: sum of 2 quarters · filed 2019-06-05 | -$104.00K 10-Q · filed 2019-06-05 | |||
| 2018-01-31 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | -$107.00K 10-Q · filed 2019-03-12 | -$439.00K 10-Q · filed 2018-03-12 | |||
| 2017-11-16 | -$252.00K 10-Q · filed 2018-03-12 | |||||
| 2017-10-31 | -$104.00K 10-Q · filed 2018-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |